Form4insider filings, from the source

SEC Form 4 · accession 0001239241-15-000001

Juno Therapeutics, Inc. · JUNO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 17, 2015
Accepted (ET)
Jun 19, 2015 · 8:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jun 17, 2015S90,141$51.59D1,659,858IBy Funds
Common StockF4,F5Jun 17, 2015S94,080$52.65D1,565,778IBy Funds
Common StockF6,F7Jun 17, 2015S63,574$53.84D1,502,204IBy Funds
Common StockF8,F9Jun 17, 2015S28,603$54.70D1,473,601IBy Funds
Common StockF10,F11Jun 17, 2015S11,602$55.85D1,461,999IBy Funds
Common StockF12,F13Jun 17, 2015S12,000$56.32D1,449,999IBy Funds
Common StockF14,F15Jun 18, 2015S78,569$52.07D1,371,430IBy Funds
Common StockF16,F17Jun 18, 2015S154,495$52.74D1,216,935IBy Funds
Common StockF18,F19Jun 18, 2015S50,269$53.58D1,166,666IBy Funds
Common Stockholding———75,000D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses